Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Radiol ; 89(1059): 20150460, 2016.
Article in English | MEDLINE | ID: mdl-26689092

ABSTRACT

OBJECTIVE: To use a Likert scale method to optimize image quality (IQ) for cone beam CT (CBCT) soft-tissue matching for image-guided radiotherapy of the prostate. METHODS: 23 males with local/locally advanced prostate cancer had the CBCT IQ assessed using a 4-point Likert scale (4 = excellent, no artefacts; 3 = good, few artefacts; 2 = poor, just able to match; 1 = unsatisfactory, not able to match) at three levels of exposure. The lateral separations of the subjects were also measured. The Friedman test and Wilcoxon signed-rank tests were used to determine if the IQ was associated with the exposure level. We used the point-biserial correlation and a χ(2) test to investigate the relationship between the separation and IQ. RESULTS: The Friedman test showed that the IQ was related to exposure (p = 2 × 10(-7)) and the Wilcoxon signed-rank test demonstrated that the IQ decreased as exposure decreased (all p-values <0.005). We did not find a correlation between the IQ and the separation (correlation coefficient 0.045), but for separations <35 cm, it was possible to use the lowest exposure parameters studied. CONCLUSION: We can reduce exposure factors to 80% of those supplied with the system without hindering the matching process for all patients. For patients with lateral separations <35 cm, the exposure factors can be reduced further to 64% of the original values. ADVANCES IN KNOWLEDGE: Likert scales are a useful tool for measuring IQ in the optimization of CBCT IQ for soft-tissue matching in radiotherapy image guidance applications.


Subject(s)
Cone-Beam Computed Tomography , Prostate/diagnostic imaging , Prostate/radiation effects , Prostatic Neoplasms/radiotherapy , Radiotherapy Planning, Computer-Assisted/methods , Humans , Male , Prostatic Neoplasms/diagnostic imaging , Radiotherapy Dosage
2.
PLoS One ; 8(10): e77435, 2013.
Article in English | MEDLINE | ID: mdl-24155955

ABSTRACT

INTRODUCTION: Polymer-based delivery systems offer innovative intra-cavity administration of drugs, with the potential to better target micro-deposits of cancer cells in brain parenchyma beyond the resected cavity. Here we evaluate clinical utility, toxicity and sustained drug release capability of a novel formulation of poly(lactic-co-glycolic acid) (PLGA)/poly(ethylene glycol) (PEG) microparticles. METHODS: PLGA/PEG microparticle-based matrices were molded around an ex vivo brain pseudo-resection cavity and analyzed using magnetic resonance imaging and computerized tomography. In vitro toxicity of the polymer was assessed using tumor and endothelial cells and drug release from trichostatin A-, etoposide- and methotrexate-loaded matrices was determined. To verify activity of released agents, tumor cells were seeded onto drug-loaded matrices and viability assessed. RESULTS: PLGA/PEG matrices can be molded around a pseudo-resection cavity wall with no polymer-related artifact on clinical scans. The polymer withstands fractionated radiotherapy, with no disruption of microparticle structure. No toxicity was evident when tumor or endothelial cells were grown on control matrices in vitro. Trichostatin A, etoposide and methotrexate were released from the matrices over a 3-4 week period in vitro and etoposide released over 3 days in vivo, with released agents retaining cytotoxic capabilities. PLGA/PEG microparticle-based matrices molded around a resection cavity wall are distinguishable in clinical scanning modalities. Matrices are non-toxic in vitro suggesting good biocompatibility in vivo. Active trichostatin A, etoposide and methotrexate can be incorporated and released gradually from matrices, with radiotherapy unlikely to interfere with release. CONCLUSION: The PLGA/PEG delivery system offers an innovative intra-cavity approach to administer chemotherapeutics for improved local control of malignant brain tumors.


Subject(s)
Brain Neoplasms/drug therapy , Drug Delivery Systems , Lactic Acid/chemistry , Polyethylene Glycols/chemistry , Polyglycolic Acid/chemistry , Animals , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/radiotherapy , Cell Death/drug effects , Cell Line, Tumor , Chemotherapy, Adjuvant , Etoposide/pharmacology , Etoposide/therapeutic use , Humans , Magnetic Resonance Imaging , Male , Mice , Mice, Nude , Polylactic Acid-Polyglycolic Acid Copolymer , Sheep , Tomography, X-Ray Computed , Xenograft Model Antitumor Assays
3.
Phys Med Biol ; 50(20): N251-5, 2005 Oct 21.
Article in English | MEDLINE | ID: mdl-16204866

ABSTRACT

Digitally reconstructed radiographs (DRRs) have become an important tool in radiotherapy treatment planning and treatment verification but their use can be limited by poor image quality. A point phantom comprised of a 1 mm diameter tungsten carbide ball bearing in a wax block has been manufactured as a means of determining a quantitative measure of DRR spatial resolution by calculating the modulation transfer function (MTF) of the image. This method is an alternative to the more often used bar pattern method. The effect of varying CT slice thickness upon DRR spatial resolution has been assessed and a power law relationship between the two variables has been established.


Subject(s)
Phantoms, Imaging , Radiographic Image Enhancement/instrumentation , Radiographic Image Interpretation, Computer-Assisted/instrumentation , Radiotherapy Planning, Computer-Assisted/instrumentation , Tomography, X-Ray Computed/instrumentation , Equipment Design , Equipment Failure Analysis , Radiographic Image Enhancement/methods , Radiographic Image Interpretation, Computer-Assisted/methods , Radiotherapy Planning, Computer-Assisted/methods , Reproducibility of Results , Sensitivity and Specificity , Tomography, X-Ray Computed/methods
4.
Med Dosim ; 29(3): 161-5, 2004.
Article in English | MEDLINE | ID: mdl-15324911

ABSTRACT

Diodes are now commercially available for use in electron beams. This paper aims to assess their response and limitations under different clinical conditions. Parameters considered were applicator factors, focus skin distance (FSD), angle of incidence, and temperature dependence. The beam perturbation was also measured. The beam energies used varied from 5 to 17 MeV. Applicator factors, measured at the surface of a phantom, differed by up to 7% compared with ion chamber measurements at Dmax. Similarly, large differences were found in FSD dependence. The temperature dependence was found to be approximately double the manufacturer's specification at 0.7% per degree Centigrade and the angular dependence was within the specification of +/- 2% for angles of +/- 30 degrees. The beam perturbation was measured as a maximum of 25% for 5-MeV electrons. The measurements were compared to other published data but this is highly dependent on the methodology employed. It was concluded that the diodes could be used in some circumstances, but only if used with extreme caution. An extensive set of commissioning measurements would be required before introducing the diodes into use clinically.


Subject(s)
Electronics/instrumentation , Radiometry/instrumentation , Radiotherapy, High-Energy/instrumentation , Electrons/therapeutic use , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...